AVID BIOSERVICES INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
AVID BIOSERVICES INC. - More news...
AVID BIOSERVICES INC. - More news...
- Avid Bioservices Announces Pricing of Public Offering of Common Stock
- Avid Bioservices Announces Proposed Public Offering of Common Stock
- Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
- Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments
- Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
- Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020
- Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020
- Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments
- Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
- Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020
- Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001
- Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing and Drug Product Parenteral Manufacturing
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2020 and Recent Developments
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2020 After Market Close on June 30, 2020
- Avid Bioservices Names Nicholas Green as President and Chief Executive Officer
- Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
- Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing
- Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia
- Avid Bioservices Receives Five 2020 CMO Leadership Awards
- Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments
- Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
- Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020
- Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer
- Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments
- Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
- Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019
- Avid Bioservices Names Richard Richieri as Chief Operations Officer
- Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure